{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Hydrogel&page=2", "query": { "intervention": "Hydrogel", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Hydrogel&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-12T00:26:53.153Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05529134", "title": "Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Dystrophic Epidermolysis Bullosa" ], "interventions": [ { "name": "PTW-002 10 mg/g gel", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Phoenicis Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 8, "start_date": "2023-04-30", "completion_date": "2024-07-31", "has_results": false, "last_update_posted_date": "2023-03-31", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 3, "location_summary": "Stanford, California • Worcester, Massachusetts • Cincinnati, Ohio", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Worcester", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05529134" }, { "nct_id": "NCT07035925", "title": "Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fistula in Ano" ], "interventions": [ { "name": "ECMT-100", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "ECM Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2025-11-24", "completion_date": "2028-04-24", "has_results": false, "last_update_posted_date": "2026-03-31", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 2, "location_summary": "Lebanon, New Hampshire • Pittsburgh, Pennsylvania", "locations": [ { "city": "Lebanon", "state": "New Hampshire" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07035925" }, { "nct_id": "NCT00828711", "title": "Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cervical Ripening", "Induction of Labor" ], "interventions": [ { "name": "MVI 100", "type": "DRUG" }, { "name": "MVI 150", "type": "DRUG" }, { "name": "MVI 200", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ferring Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 374, "start_date": "2009-04", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Long Beach, California + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00828711" }, { "nct_id": "NCT05535738", "title": "Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Skin Inflammation", "Allergic Contact Dermatitis" ], "interventions": [ { "name": "Squaric Acid Dibutyl Ester", "type": "DRUG" }, { "name": "Known patch test allergens", "type": "OTHER" }, { "name": "Dupilumab", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Ustekinumab", "type": "DRUG" }, { "name": "Guselkumab", "type": "DRUG" }, { "name": "Canakinumab", "type": "DRUG" }, { "name": "Sarilumab", "type": "DRUG" }, { "name": "Triamcinolone Acetonide", "type": "DRUG" }, { "name": "Betamethasone Valerate", "type": "DRUG" }, { "name": "Fluticasone Propionate", "type": "DRUG" }, { "name": "Microneedle", "type": "DEVICE" }, { "name": "Suction blistering", "type": "DEVICE" }, { "name": "Skin punch biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "DEVICE", "PROCEDURE" ], "sponsor": "Wei-Che Ko", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2022-11-15", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-06-09", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 1, "location_summary": "Worcester, Massachusetts", "locations": [ { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05535738" }, { "nct_id": "NCT06914596", "title": "A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Periodontitis (Stage 3)" ], "interventions": [ { "name": "Emanate Perio PODS", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "McGuire Institute", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "30 Years to 75 Years" }, "enrollment_count": 72, "start_date": "2026-02-19", "completion_date": "2027-01-30", "has_results": false, "last_update_posted_date": "2026-06-24", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 8, "location_summary": "Fullerton, California • New London, Connecticut • Boston, Massachusetts + 5 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "New London", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "La Vista", "state": "Nebraska" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06914596" }, { "nct_id": "NCT01966770", "title": "Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Myopia" ], "interventions": [ { "name": "Pair 1 (ocufilcon D / ocufilcon D)", "type": "DEVICE" }, { "name": "Pair 2 (ocufilcon D / enfilcon A)", "type": "DEVICE" }, { "name": "Pair 3 (ocufilcon D / comfilcon A)", "type": "DEVICE" }, { "name": "Pair 4 (methafilcon A / methafilcon A)", "type": "DEVICE" }, { "name": "Pair 5 (methafilcon A / comfilcon A)", "type": "DEVICE" }, { "name": "Pair 6 (omafilcon A / comfilcon A)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "CooperVision, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 20, "start_date": "2013-10", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2020-07-30", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 1, "location_summary": "Berkeley, California", "locations": [ { "city": "Berkeley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01966770" }, { "nct_id": "NCT04927702", "title": "Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Foot Ulcer", "Venous Leg Ulcer" ], "interventions": [ { "name": "Synthetic Hybrid-Scale Fiber Matrix", "type": "DEVICE" }, { "name": "Standard of Care", "type": "DEVICE" }, { "name": "Living Cellular Skin Substitute", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Acera Surgical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2021-07-19", "completion_date": "2024-08-01", "has_results": true, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 6, "location_summary": "Vista, California • Jacksonville, Florida • Miami Beach, Florida + 3 more", "locations": [ { "city": "Vista", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04927702" }, { "nct_id": "NCT07060495", "title": "RADA16 for Adult Tonsillectomy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "RADA16 hydrogel", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 134, "start_date": "2025-09-12", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 2, "location_summary": "Livingston, New Jersey • Newark, New Jersey", "locations": [ { "city": "Livingston", "state": "New Jersey" }, { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07060495" }, { "nct_id": "NCT05157958", "title": "Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dystrophic Epidermolysis Bullosa" ], "interventions": [ { "name": "ALLO-ASC-SHEET", "type": "BIOLOGICAL" }, { "name": "Vehicle Control", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Anterogen Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "4 Years to 60 Years" }, "enrollment_count": 6, "start_date": "2023-05-01", "completion_date": "2026-04-28", "has_results": false, "last_update_posted_date": "2024-04-22", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05157958" }, { "nct_id": "NCT04702984", "title": "Clinical Characterization of an Investigational Frequent Replacement Daily Wear Silicone Hydrogel Sphere Contact Lens", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Refractive Errors" ], "interventions": [ { "name": "LID021201 contact lenses", "type": "DEVICE" }, { "name": "OPTI-FREE multipurpose solution", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2021-01-21", "completion_date": "2021-02-26", "has_results": true, "last_update_posted_date": "2022-03-16", "last_synced_at": "2026-09-12T00:26:53.153Z", "location_count": 3, "location_summary": "Maitland, Florida • Memphis, Tennessee • Wichita Falls, Texas", "locations": [ { "city": "Maitland", "state": "Florida" }, { "city": "Memphis", "state": "Tennessee" }, { "city": "Wichita Falls", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04702984" } ] }